L-Mesitran

DEVICE2 trials

Sponsors

Maastricht University Medical Center

Conditions

Candidiasis, VulvovaginalRecurrent Candidiasis of Vagina

Phase 3

The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms

RecruitingNCT05367089

Maastricht University Medical CenterCandidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina

Start: 2022-08-22End: 2027-04-22Target: 252Updated: 2023-05-17

Phase 4

Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis

Maastricht University Medical CenterCandidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina

Start: 2021-03-01End: 2025-03-01Target: 252Updated: 2020-11-12

Related Papers

Efficacy of a medical grade honey formulation (L-Mesitran) in comparison with fluconazole in the treatment of women with recurrent vulvovaginal candidiasis: protocol for a randomised controlled trial (HONEY STUDY)

BMJ Open2023-08-011 citations